Urolithin A for Longevity: What the Science Supports

“Longevity” is one of the most over-promised words in wellness. This guide takes the opposite approach: it separates what human research on urolithin A actually supports from what remains preclinical, so you can decide with clear eyes rather than hype.

What “longevity” honestly means here

When most people say they want to live longer, what they really want is to stay strong, energetic and independent for as long as possible — the concept researchers call healthspan rather than raw lifespan. That distinction matters enormously for how we read the science on urolithin A. No human study has shown that any supplement extends the human lifespan, and SOMA HEALTH will never claim otherwise. What a growing body of human research does explore is whether urolithin A can support the cellular machinery that tends to falter as we age, and whether that translates into measurable differences in things like muscle endurance and cellular energy markers.

So the honest framing is this: urolithin A is being studied as a tool to support healthy aging at the cellular level. It is not an anti-aging cure, it does not reverse the clock, and it is not a substitute for the fundamentals — sleep, resistance training, protein, and managing chronic conditions with your doctor. With that boundary set, the mechanism is genuinely interesting.

The mechanism: mitophagy and worn-out mitochondria

Mitochondria are the structures inside your cells that turn food and oxygen into usable energy. Like any hardworking machinery, they wear out. A healthy young cell continuously identifies damaged mitochondria and recycles them through a quality-control process called mitophagy — literally “mitochondria eating.” The problem is that this recycling process becomes less efficient with age, so damaged mitochondria accumulate and cellular energy output tends to decline. This slow decay of mitochondrial health is one of the recognized hallmarks of biological aging.

Urolithin A is a gut postbiotic — your body does not get it directly from food. Instead, your gut bacteria produce it from ellagitannins, compounds found in pomegranates, walnuts and certain berries. The catch is that only some people carry the specific microbiome needed to convert those precursors into meaningful amounts of urolithin A; estimates suggest a substantial share of people are poor converters. That is a key reason a standardized supplement exists at all: it delivers a consistent dose regardless of your gut chemistry. In laboratory and animal research, urolithin A works by nudging mitophagy back toward that youthful, efficient state — clearing out worn mitochondria so the cell can maintain cleaner, more functional energy production. You can read a fuller explainer in our urolithin A guide.

What the strongest human evidence supports

Here is where the longevity conversation should live: in the human trials, organized by what they actually measured.

Safety and the mitochondrial signature

The first-in-human work, Andreux and colleagues (2019, Nature Metabolism), established that urolithin A was safe and well tolerated at doses up to 1,000 mg per day, and — importantly for the aging story — it produced a mitochondrial gene-expression signature in participants, biological evidence that the compound was engaging the pathways seen in the lab work.

Muscle endurance and strength

Two randomized human trials moved the story from biomarkers to function. Liu, D'Amico and colleagues (2022, JAMA Network Open) studied older adults over roughly four months and reported improvements in muscle endurance, measured as the number of muscle contractions performed before fatigue. Singh and colleagues (2022, Cell Reports Medicine) studied middle-aged adults over four months across 500 mg and 1,000 mg arms and reported benefits in muscle strength and aspects of exercise performance. Muscle is central to the healthspan conversation — preserving strength and stamina is one of the clearest, most functional expressions of aging well.

Newer human evidence: immune-cell aging and athletic recovery

More recent human work has widened the lens. A 2025 randomized trial published in Nature Aging found that a roughly 28-day course supported the mitochondrial health of immune cells in midlife adults — relevant to “inflammaging,” the low-grade inflammation that tends to rise with age. A 2024 8-week randomized trial in the Journal of the International Society of Sports Nutrition examined resistance-trained men and looked at endurance and recovery markers, and a 2025 trial in distance runners added further data in trained populations. These are newer and should be read as promising rather than settled.

Where the “lifespan” idea actually comes from — and its limits

The eye-catching “longevity” headlines trace back to preclinical work, and it is essential to label it as such. Ryu and colleagues (2016, Nature Medicine) is the foundational study: in that research, urolithin A induced mitophagy, extended lifespan in the worm C. elegans, and improved muscle function in rodents. This is genuinely important science, but it is animal and cell research — a nematode is not a person, and extending a worm's lifespan does not demonstrate anything about human longevity. Treat these findings as the biological rationale that motivated the human trials, not as proof of a human benefit.

The same care applies to other tissues. Preclinical research is exploring urolithin A's role in joint and cartilage mitochondrial health (D'Amico et al., 2022, Aging Cell, in osteoarthritis models), as well as early-stage work touching skin, gut, brain and heart tissue. Each of these is worth watching, but none has the weight of a completed human outcome trial, and none should be read as a treatment for any condition.

Honest limitations

A 2024 systematic review in Ageing Research Reviews, “Targeting aging with urolithin A in humans,” reached a measured conclusion that is worth internalizing: the human evidence is still emerging, the trials so far have been relatively short and modest in size, and the outcomes are mostly functional and biomarker-based rather than long-term. In plain terms, urolithin A has a credible mechanism and encouraging early human data on muscle and cellular-energy markers, but it has not been shown to make people live longer, and it is not a shortcut around the basics of healthy aging. Because aging intersects with real medical conditions, urolithin A is a supplement that supports cellular health — it is not a treatment for any disease, and you should see your doctor for any health concern or before adding it alongside medications.

How to use it as part of a longevity-minded routine

If you decide to try urolithin A, think of it as one supporting input, not the centerpiece. The daily serving studied for functional benefits sits in the 500–1,000 mg range; consistency over months matters more than any single dose, since the trials that showed muscle benefits ran for around four months. Pair it with the interventions that have the deepest evidence for healthy aging — regular resistance training to preserve muscle, adequate protein, quality sleep, and staying on top of blood pressure, glucose and cholesterol with your physician. For more on realistic timelines see how long urolithin A takes to work, and if you are comparing products, our roundup of the best urolithin A gummies walks through what to look for on a label.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.